Tectonic Therapeutic Inc
NASDAQ:TECX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Tectonic Therapeutic Inc (TECX) under the Base Case is 1.29 USD per share.
Compared with the current market price of 21.97 USD, the stock appears
Overvalued by 94% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Tectonic Therapeutic Does
AVROBIO Inc. is a biotechnology company that develops gene therapies for rare inherited diseases. Its core idea is to take a patient’s own blood-forming stem cells, add a working copy of a faulty gene in the lab, and put the corrected cells back into the body. The goal is to treat the root cause of the disease rather than manage symptoms with lifelong medicines.
- Headquarters
- United States of America US
- Employees
- 60
- IPO date
- Jun 21, 2018
Earnings Waterfall
Tectonic Therapeutic Inc
What is the Intrinsic Value of one TECX stock?
The intrinsic value for Tectonic Therapeutic Inc (TECX) under the Base Case is 1.29 USD.
Is TECX stock undervalued or overvalued?
Compared with the current market price of 21.97 USD, the stock appears Overvalued by 94% .
